SMURF2 and lip and oral cavity carcinoma: This study aims to provide a deeper understanding of the TGF-β pathway’s involvement in oral cancer, offering novel insights into the prognostic significance of TRGs and highlighting SMURF2 as a potential biomarker for prognosis and immune efficacy evaluation in oral cancer.